Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control.

Stem Cells Int · 2022 · PMC9568364 · PMID 36248254

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

This might be significant given that age is a factor in the prevalence, morbidity, and mortality of some diseases [ 35 ]. iPSC-MSCs also secreted abundant factors which can suppress inflammatory-like stem cell factor (SCF) [ 35 ], monocyte chemotactic protein 1 (MCP) [ 36 ], TGF- β 1/2/3 [ 33 ], and FGF21 [ 37 ].

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.